Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Maceron Jul 08, 2019 10:07pm

143 Views

Post# 29897473

RE:RE:RE:Ph. 2 N-803 with BCG in BCG-unresponsive NMIBC

enriquesuave wrote: Those are pretty good results there. However I think we will beat them with only 2 instillations versus 15 and they had 3 serious AE’s , so not as safe, but I would still say very good.

There is also a shortage of BCG which makes this combination self limiting. And 15 treratments takes time, time which these patients do not have before possible progression to muscle invasive cancer and mets. I wouldn't take the risk if I was the patient.
Macer

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading